Showing results (181-190 of 240) with videos related to

Sort By:
Pageof 24
Archiv Der Pharmazie|June 20, 2023
Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostatYoussef Y Helmi, Niklas Papenkordt, Georg Rennar, et al.
Experimental and Molecular Pathology|September 21, 2014
Inhibition of p300 suppresses growth of breast cancer. Role of p300 subcellular localizationMaría E Fermento, Norberto A Gandini, Débora G Salomón, et al.
Plos Pathogens|May 10, 2014
Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasisVitor Coutinho Carneiro, Isabel Caetano de Abreu da Silva, Eduardo José Lopes Torres, et al.
Oncotarget|December 16, 2014
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cellsCordula A Jilg, Anett Ketscher, Eric Metzger, et al.
Journal of Cancer Research and Clinical Oncology|January 24, 2022
Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myelomaJohannes M Waldschmidt, Stefan J Fruttiger, Dagmar Wider, et al.
Archiv Der Pharmazie|July 15, 2024
Soft drug inhibitors for the epigenetic targets lysine-specific demethylase 1 and histone deacetylasesJohannes Seitz, Marina Auth, Tony Prinz, et al.
Future Medicinal Chemistry|August 25, 2016
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studiesMargherita Brindisi, Caterina Cavella, Simone Brogi, et al.
Journal of Medicinal Chemistry|August 31, 2012
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cellsDante Rotili, Domenico Tarantino, Vincenzo Carafa, et al.
RSC Chemical Biology|November 7, 2024
A nanoengineered tandem nitroreductase: designing a robust prodrug-activating nanoreactorMariia Zmyslia, Michael J Capper, Michael Grimmeisen, et al.
International Journal of Molecular Sciences|July 27, 2022
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma ActivitySalma Darwish, Ehab Ghazy, Tino Heimburg, et al.
Pageof 24